This year BIO Asia–Taiwan 2022 Onsite + Online will continue in a mixed online + live format, this year to be held July 28-31, with early access starting July 25. The event aims to build on the success of recent years’gatherings to again bring together biotechnology and pharmaceutical executives and investors from North America, Europe and Asia, and explore business opportunities with Taiwan’s emerging biotech sector.
【Singapore Webinar】Effortless workflow from protein design to protein analysis
2022-06-22
Our Singapore distributor, Biomed Global, will hold a webinar to introduce protein application on Qsep platform on 30th of June 3 PM(SGT). Please feel free to join this event.
Congratulations! BiOptic's Analysis Software has certified by IEC 62304!
2022-04-07
BiOptic Inc., as a biotechnology company with R&D, manufacturing, and marketing momentum. To extend the product market to clinical related fields, we followed all software develop guidelines for BiOptic instrument products and has been certified by FDA 21 CFR Part 11. Recently, the operation and database control system: Q-Analyzer and Qamp Master Micro PCR program software are also certified by IEC 62304.
BiOptic’s innovative CE products are listed in the 2022 Market & Research Report !
2022-03-28
BiOptic’s innovative CE products are well positioned within the multi-million dollar Capillary Electrophoresis (CE) Market and rapidly gaining ground to be the industry leader.
BiOptic Inc., Giant Bio Technology Inc. and NTOU have jointly publised a journal article on MDPI
2022-02-17
According to the 2018 market survey report, the global farmed shrimp market is about 28 billion U.S. dollars. Due to the globalization and high-density of aquaculture industry, the spread of diseases has accelerated. Among them, shrimp infectious diseases will outbreak every few years, including white Spot disease (WSD), acute hepatopancreatic necrosis disease (AHPND), and hepatopancreatic microsporidia (HPM), which reduce the industry profit with an estimated $7.8 billion annually.
